Skip to main content

Table 1 Prevalence of SP mutant SNPs and haplotypes between 2012 and 2017

From: Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya

Gene

SNP

Percent in 2012

Percent in 2017

P value

Pfdhfr

 

n = 212

n = 111

 

C50R

0

0

N/A

N51I

100

100

1.000

C59R

97.2

96.4

0.965

S108N

100

100

1.000

I164L

0.9

0

0.779

Pfdhps

 

n = 210

n = 111

 

S436H

10.5

34.6

0.001

A437G

100

100

1.000

K540E

99.5

97.2

0.221

A581G

1.0

0

0.792

 

A613T

0

0

N/A

Mutation number

Haplotype

Percent in 2012

Percent in 2017

P value

Pfdhfr

 

n = 212

n = 111

 

Wild

C50N51C59S108I164

0

0

N/A

Double

C50I51C59N108I164

2.3

3.6

0.772

Triple

C50I51R59N108I164

96.7

96.4

0.965

Triple

C50I51C59N108L164

0.5

0

1.000

Quadruple

C50I51R59N108L164

0.5

0

1.000

Pfdhps

 

n = 210

n = 107

 

Wild

S436A437K540A581A613

0

0

N/A

Single

S436G437K540A581A613

0.5

2.8

0.221

Double

S436G437E540A581A613

88.1

62.6

0.001

Triple

H436G437E540A581A613

10.5

34.6

0.001

Triple

S436G437E540G581A613

1.0

0

0.793

dhfr/dhps

 

n = 209

n = 107

 

Wild

C50N51C59S108I164/S436A437K540A581A613

0

0

N/A

Triple

C50I51C59N108I164/S436G437K540A581A613

0

1

1.000

Quadruple

C50I51C59N108I164/S436G437E540A581A613

2.4

2.8

1.000

Quadruple

C50I51R59N108I164/S436G437K540A581A613

0.5

1.9

0.553

Quintuple

C50I51R59N108I164/S436G437E540A581A613

85.2

59.8

0.001

Sextuple

C50I51R59N108I164/H436G437E540A581A613

10.1

34.6

0.001

Sextuple

C50I51C59N108L164/H436G437E540A581A613

0.5

0

1.000

Sextuple

C50I51R59N108L164/S436G437E540A581A613

0.5

0

1.000

Sextuple

C50I51R59N108I164/S436G437E540G581A613

1.0

0

0.791

  1. P-values in bold indicate statistically significant differences in the prevalence of resistant markers between 2012 and 2017
  2. N/A not applicable